ATECAlphatec Holdings, Inc.

Surgical case volume surged 20% as EOS Insight adoption accelerated.

Alphatec Holdings, Inc. recently reported past second-quarter 2026 results showing its net loss narrowed to US$25.78 million, or US$0.16 per share, and reaffirmed full-year 2026 revenue guidance of about US$882 million, including US$805 million of surgical revenue and US$77 million of EOS revenue. Alongside filing an US$8.12 million employee stock ownership plan shelf registration, the company’s reduced losses and maintained outlook highlight management’s confidence in its current growth and...

Moby summary of Alphatec Holdings, Inc.'s Q2 2026 earnings call

Alphatec Holdings Inc (ATEC) delivered 15% revenue growth and raised its full-year adjusted EBITDA outlook, while navigating a slower-than-expected biologics attachment recovery.

Alphatec (ATEC) delivered earnings and revenue surprises of -22.22% and +1.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Alphatec (NASDAQ:ATEC) reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier, as growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow. Chairman and CEO Pat Miles said surgical revenue rose 17% to $196 million, while

Over the last 7 days, the United States market has experienced a 1.0% drop, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this context, identifying growth companies with strong insider ownership can be an effective strategy as these firms often demonstrate commitment and confidence from those who know them best.